Lenovo Becomes Global Partner of Formula 1® in Renewed Deal
5.9.2024 17:00:00 CEST | Business Wire | Press release
Formula 1® and Lenovo have today announced the extension of its partnership that will see the technology giant elevated to a Global Partner in a multi-year renewal starting from the beginning of 2025. As part of the deal, Motorola, a subsidiary of Lenovo Group, will become Global Smartphone Partner of F1.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905029431/en/
(Photo: Business Wire)
As a Global Partner of Formula 1, Lenovo will continue to provide F1 with state-of-the-art technology devices, solutions and services to support the delivery of Grands Prix at track and remotely. Under the agreement, Lenovo will serve as the title sponsor for two races per season and Lenovo and Motorola will have increased trackside branding at events.
Since 2022, Lenovo technology has been at the heart of F1’s operations as an Official Partner. Through its on-site High-Performance Computing (HPC) solutions, servers and edge devices, Lenovo has been supporting Formula 1 in its delivery of its best-in-class broadcast product, bringing the drama and excitement of F1 to millions of fans around the world, with a truly global team that’s always-on. Lenovo hardware – including laptops, workstations, desktop computers and monitors, as well as tablets and Motorola smartphones – provide F1 staff with high-quality equipment to create engaging, customised content for the sport’s ever expanding and passionate fanbase.
Additionally, Lenovo’s Asset Recovery Service supports F1’s wider sustainability strategy, alongside its efforts to reduce emissions and reach Net Zero by 2030. Lenovo’s Asset Recovery Service helps ensure that retired computing hardware is recycled in a socially and environmentally conscious manner. Since the beginning of the partnership, F1 has sustainably disposed 95% of obsolete hardware, which ultimately helps to reduce costs and mitigate security risks through reliable data destruction with enhanced security.
Throughout the partnership, Lenovo has aimed to integrate smarter technology into the sport. The world’s first kiss-activated trophies at the FORMULA 1 LENOVO JAPANESE GRAND PRIX 2023 and FORMULA 1 LENOVO UNITED STATES GRAND PRIX 2023, along with this year’s laurel wreath design, combining tradition and innovation, elevated the podium celebrations and serve as strong symbols of Lenovo’s drive for purposeful design and cutting-edge technology.
In recent years, F1 has seen a significant growth in popularity, with increased television audiences, record attendance and fan engagement across all platforms. Both F1 and Lenovo share a commitment to sustainability and the exploration of next generation technologies, like Lenovo AI PCs, AI-enabled Motorola smartphones and AR/VR solutions.
Through direct collaboration between F1’s technical teams and Lenovo’s Centres of Excellence, highly innovative solutions are being found to a variety of challenges, such as the use of onsite and Edge Compute AI solutions to improve operational efficiency during live F1 broadcasts. Together, F1 and Lenovo will continue to build on years of successful collaboration to develop the future of the sport.
Stefano Domenicali, CEO and President of Formula 1 said:
“I am delighted that Lenovo will become a Global Partner of Formula 1. Since joining the sport Lenovo’s creativity and passion for technology and innovation have supported F1’s ambitions to create more once-in-a-lifetime moments for fans. Today marks a new chapter in a partnership that will only continue to grow from strength to strength. I look forward to continuing our work with Lenovo and using our shared commitment to precision, innovation, and sustainability to ensure F1 remains the world’s most technologically advanced sport for years to come.”
Yang Yuanqing, Chairman & CEO of Lenovo, said:
"We are thrilled to elevate our partnership to the next level becoming a Global Partner of Formula 1. Our vision at Lenovo is to harness the power of AI to create a smarter, more inclusive, and sustainable world, accessible to everyone. Through our groundbreaking partnerships, like the one with Formula 1, we are pushing the boundaries of innovation and performance. Together, we’re not just shaping the future of technology and motorsport, but we’re also ensuring that cutting-edge technological advancements benefit all, creating unforgettable experiences no matter where they are in the world."
Luca Rossi, President of Intelligent Devices Group, Lenovo, said:
“When we embarked on our journey with F1 three years ago, we knew they were the right partner for Lenovo as our brand values seamlessly aligned for a smarter, faster, and more sustainable future. Seeing our high-performance technology implemented across every level of the F1 organization fills us with pride, and our close collaboration together has just begun. We look forward to taking our partnership to newer heights and continue having Lenovo’s AI-ready hardware, as well as our solutions and services, transform and benefit the fan experience worldwide.”
About Formula 1®
Formula 1® racing began in 1950 and is the world’s most prestigious motor racing competition, as well as the world’s most popular annual sporting series. Formula One World Championship Limited is part of Formula 1® and holds the exclusive commercial rights to the FIA Formula One World Championship™. Formula 1® is a subsidiary of Liberty Media Corporation (NASDAQ: LSXMA, LSXMB, LSXMK, FWONA, FWONK, LLYVA, LLVYK) attributed to the Formula One Group tracking stock. The F1 logo, F1 FORMULA 1 logo, FORMULA 1, F1, FIA FORMULA ONE WORLD CHAMPIONSHIP, GRAND PRIX, PADDOCK CLUB and related marks are trademarks of Formula One Licensing BV, a Formula 1 company. All rights reserved.
About Lenovo
Lenovo is a US$57 billion revenue global technology powerhouse, ranked #217 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a pocket-to cloud portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (server, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905029431/en/
Contacts
Formula 1 Press Office
Formula 1 Press Office
E: f1media@f1.com
T: @f1media
Note: If you no longer wish to receive these emails, please write to f1media@f1.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom